The Number 1 Small-Cap Biotech Investors are Missing Out On Post author:Sam Post published:December 26, 2017 Post category:BioPharma A look at a small-cap biotech company that investors should consider. Source: BioSpace You Might Also Like With Plans for U.S. and China Manufacturing Plants, Athenex Gears Up for $100 Million IPO May 15, 2017 Alere Coughs Up $13 Million to Settle Accounting Fraud Charges With the September 28, 2017 Inovio Pharma To Report First Quarter 2017 Financial Results May 10, 2017 April 25, 2017
With Plans for U.S. and China Manufacturing Plants, Athenex Gears Up for $100 Million IPO May 15, 2017
